Transplant Genomics is committed to improving long-term organ transplant outcomes with non-invasive genomic biomarker monitoring.
Framingham, MA
Joined May 2015
- Tweets1.1K
- Following672
- Followers337
- Likes1.5K
TruGraf® Kidney is a validated blood-based biomarker test designed to support surveillance in clinically stable kidney transplant patients, offering a noninvasive alternative to surveillance biopsy.
Learn more: brnw.ch/21x6KUi
#Eurofins #KidneyTransplant
In 1976, Larry Rogers, 10, received a kidney from his 12-year-old sister. 50 years later, that same kidney is still going strong, a milestone worth celebrating.
Read more from @transplantnews: brnw.ch/21x6JdM
#Eurofins #LivingDonor #GiftOfLife
Elevated dd-cfDNA signals kidney distress, but not the cause. Eurofins TRAC™ plus ID adds viral DNA detection to the same test, helping clinicians tell rejection apart from infection.
Learn more: brnw.ch/21x6Hso
#Eurofins #KidneyTransplant
Combining biomarker classes strengthens rejection detection and now links to long-term graft survival data, but biopsy still isn't optional.
Read more: brnw.ch/21x6ASX
#Eurofins #Nephrology #PrecisionMedicine
At 2 years, eGFR looked identical between biomarker-positive and negative patients. Yet the data show that biomarker-positive patients had roughly 4x the risk of graft loss, a signal standard labs missed.
Read more: brnw.ch/21x6zfF
#Eurofins #KidneyHealth
Combining dd-cfDNA with gene expression profiling boosted rejection-detection accuracy to an AUC of 0.81, outperforming either test alone.
Read it here: brnw.ch/21x6xEh
#Eurofins #Nephrology #KidneyTransplant
No single biomarker tells the whole story of a transplanted kidney.
dd-cfDNA, gene expression profiling, urinary chemokines, DNA methylation, each catches something different.
Read the full review: brnw.ch/21x6mS3
#KidneyTransplant #Nephrology #Eurofins
Non-invasive, repeatable urinary biomarker testing can help guide immunosuppression decisions between biopsies, supporting more personalized care for kidney transplant recipients.
See how it fits into patient monitoring: brnw.ch/21x6gje
#Eurofins #KidneyTransplant
When a kidney transplant is under immune attack, cells release chemokines (CXCL9/CXCL10) that show up in urine.
Take a look at how urinary biomarker testing can flag early immune activation: brnw.ch/21x6esc
#Eurofins #KidneyHealth #PrecisionMedicine
Subclinical rejection can develop silently between biopsies — no symptoms, no red flags.
A new non-invasive urinary biomarker approach is changing how clinicians monitor kidney transplant patients.
Learn more: brnw.ch/21x6crf
#Eurofins #KidneyTransplant #Nephrology
Liver transplant recipient Matt Felix scored the winning goal for Team USA at the first Transplant Football World Cup. This month, he was back on the pitch in Frankfurt, Germany, proof of what organ donation makes possible.
🔗: brnw.ch/21x65NM
#Eurofins @transplantnews
Earlier clarity means earlier action.
Eurofins TRAC™ plus ID combines dd-cfDNA and viral load monitoring in one test, helping clinicians distinguish rejection from infection sooner. 🔗 brnw.ch/21x6463
#KidneyTransplant #TransplantCare #Eurofins
After rejection treatment, did it actually work? Up to 37% of patients experience persistent rejection.
Kidney360 editorial: combining GEP and dd-cfDNA may help confirm resolution without a repeat biopsy. 🔗 brnw.ch/21x62qz
#KidneyTransplant #Eurofins
Following up on the biomarker research we shared this week, we asked Christopher McCloskey what still stands in the way of moving away from biopsy. His take: cost, turnaround time, and predictive value all still have room to close.
🔗: brnw.ch/21x5VH4
#Eurofins #Biopsy
Belatacept offers real advantages over CNIs, but it requires precision monitoring to manage its risks.
Read more: brnw.ch/21x5U0Y
#Belatacept #TransplantMedicine #Eurofins
A peer-reviewed study says non-invasive kidney transplant monitoring has moved from promise to practice. Christopher McCloskey, President of Eurofins Transplant Genomics, breaks down a blind spot most people miss.
Full study: brnw.ch/21x5S7s
#Eurofins #Biomarkers
At 24, David Rush woke up with a dialysis catheter in his neck and no memory of how he got there.
Since then: a transplant, transplant failure, kidney cancer, and a music career touring.
His story: brnw.ch/21x5JjV
#KidneyDisease #KidneyTransplant #Eurofins
Biomarkers or biopsy? The answer isn't as simple as you'd think.
A webinar breaks down where noninvasive testing actually helps, and where it doesn't.
Read the full breakdown: brnw.ch/21x5HkN
#KidneyTransplant #SubclinicalRejection #Eurofins
Eurofins TRAC™ plus ID uses whole genome sequencing to assess donor-derived cell-free DNA and viral DNA from a single blood draw, providing information to support kidney transplant monitoring.
Learn more: brnw.ch/21x5AxF
#KidneyTransplant #Eurofins #TransplantCare
TruGraf® Kidney is a Gene Expression Profile test built to help rule out subclinical rejection, noninvasively, with a simple blood draw.
Fewer biopsies. More confidence between visits.
Learn more: brnw.ch/21x5yqN
#TruGraf #KidneyTransplant #Eurofins #TransplantCare
